1. Home
  2. IRIX vs ENLV Comparison

IRIX vs ENLV Comparison

Compare IRIX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.51

Market Cap

24.2M

Sector

Health Care

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.98

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
ENLV
Founded
1989
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
26.6M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
IRIX
ENLV
Price
$1.51
$0.98
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
105.1K
461.1K
Earning Date
11-11-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,647,000.00
N/A
Revenue This Year
$9.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.58
N/A
52 Week Low
$0.78
$0.66
52 Week High
$1.72
$2.10

Technical Indicators

Market Signals
Indicator
IRIX
ENLV
Relative Strength Index (RSI) 70.72 60.53
Support Level $1.22 $0.85
Resistance Level $1.54 $1.03
Average True Range (ATR) 0.11 0.07
MACD 0.03 0.03
Stochastic Oscillator 89.13 90.84

Price Performance

Historical Comparison
IRIX
ENLV

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: